Clinical Trials Directory

Trials / Unknown

UnknownNCT05310955

Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia

Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.

Detailed description

Shen-based Qigong exercise is a new kind of health-care Qigong exercise based on the theory of traditional Chinese medicine, aiming at the characteristics of schizophrenia. In this study, a randomized controlled trial was conducted to observe the rehabilitation effect of this new exercise on residual symptoms of schizophrenic patients. Questionnaire, test and other experimental materials were used to evaluate the intervention effect of 12-week shen-based Qigong exercise on psychiatric symptoms, cognitive function, quality of life and social function of schizophrenic patients. At the same time, the related physical function and cardiac function indexes were used to evaluate the physical and cardiac rehabilitation effects of the exercise on patients from the aspects of "body" and "heart", so as to verify whether Qigong exercise has the effects of adjusting body and heart.

Conditions

Interventions

TypeNameDescription
OTHERdaily rehabilitation interventionsincluding Naikan therapy, Morita therapy, group art therapy, group painting therapy
OTHERshen-based Qigong exercisea 12-week intervention of shen-based Qigong exercise : exercise 5 days a week, about 30 minutes a day

Timeline

Start date
2022-08-16
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2022-04-05
Last updated
2022-10-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05310955. Inclusion in this directory is not an endorsement.